|
Volumn 54, Issue 3, 2000, Pages 291-295
|
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
TELOMERASE;
ARTICLE;
DISEASE COURSE;
ENZYMOLOGY;
GENETICS;
HEAD AND NECK TUMOR;
HUMAN;
METABOLISM;
PROGNOSIS;
TUMOR SUPPRESSOR GENE;
DISEASE PROGRESSION;
GENES, P16;
GENES, TUMOR SUPPRESSOR;
HEAD AND NECK NEOPLASMS;
HUMANS;
PROGNOSIS;
TELOMERASE;
|
EID: 0033648996
PISSN: 00306657
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|